Paul E. Dicorleto serves as Executive at CLEVELAND BIOLABS INC, where they oversee executive responsibilities. Since joining the company, Paul E. Dicorleto has executed 6 insider transactions totaling $62.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on Jun 19, 2013 involved receiving (via award) 10,102 shares valued at $0.
Paul E. Dicorleto currently holds 41,968 shares of CLEVELAND BIOLABS INC (CBLI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Paul E. Dicorleto has been a net buyer of CBLI stock. They have purchased $62.0K and sold $0 worth of shares.
Paul E. Dicorleto's most recent insider trade was on Jun 19, 2013, when they sold 10,102 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $1.61 |
| Discretionary |
| Aug 15, 2011 | CBLI | $26.0K | Purchase | 10,000 | $2.60 | Discretionary |
| Aug 15, 2011 | CBLI | $26.0K | Purchase | 10,000 | $2.60 | Discretionary |
| Jun 8, 2010 | CBLI | $0 | Award | 8,389 | $N/A | Discretionary |
| May 18, 2010 | CBLI | $0 | Award | 7,267 | $N/A | Discretionary |